UroGen earnings for the third quarter of 2026 are scheduled for release before the stock market opens on Wednesday, November 4. The biotech company will follow the release with a conference call and live audio webcast at 10 a.m. Eastern Time.

UroGen earnings webcast and replay

UroGen Pharma announced the schedule on October 27 but did not provide third-quarter financial figures. The live public webcast will be available through the investor relations section of the company’s website.

A replay of the webcast will remain available on the site for approximately 30 days after the live event.

Company background

UroGen is a biotech company focused on developing and commercializing treatments for urothelial and specialty cancers. It is headquartered in Princeton, New Jersey, and has operations in Israel.

The company’s shares trade on Nasdaq under the ticker URGN. UroGen has developed a sustained-release hydrogel platform designed to enable longer exposure of urinary tract tissue to medications.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.